1. Structural Properties and Molecular Partnership of N~TAIL~ {#sec1-biomolecules-09-00008}
=============================================================

The nucleoprotein (N) of measles virus (MeV) consists in a large structured moiety (N~CORE~, aa 1 to 400) and in a C-terminal domain (N~TAIL~, aa 401 to 525 of N) that is intrinsically disordered \[[@B1-biomolecules-09-00008]\] ([Figure 1](#biomolecules-09-00008-f001){ref-type="fig"}A). The N~TAIL~ protrudes from the globular core of N and is exposed at the surface of the viral nucleocapsid \[[@B2-biomolecules-09-00008],[@B3-biomolecules-09-00008],[@B4-biomolecules-09-00008],[@B5-biomolecules-09-00008],[@B6-biomolecules-09-00008]\]. The latter is made of a regular array of N monomers wrapping the RNA genome into a helicoidal arrangement. The exposure of N~TAIL~ at the surface of the nucleocapsid allows recruitment of the phosphoprotein (P) via interaction with the C-terminal X domain (XD) of the latter \[[@B7-biomolecules-09-00008],[@B8-biomolecules-09-00008],[@B9-biomolecules-09-00008],[@B10-biomolecules-09-00008]\]. The phosphoprotein (P) is required for both transcription and replication, as it tethers the viral Large protein (L), which possesses all the enzymatic activities required for RNA synthesis, onto the nucleocapsid template (for a review see \[[@B11-biomolecules-09-00008]\]).

Structural disorder is known to be a determinant of protein interactivity: the enhanced plasticity of intrinsically disordered proteins (IDPs) and regions (IDRs) allows for the enlargement of their molecular partnership \[[@B12-biomolecules-09-00008],[@B13-biomolecules-09-00008],[@B14-biomolecules-09-00008]\]. In line with this, MeV N~TAIL~ binds to numerous partners. Beyond the X domain of the P protein, N~TAIL~ also interacts with the viral matrix protein \[[@B15-biomolecules-09-00008]\]. In addition, it also interacts with host proteins, such as the major inducible heat shock protein 70 (hsp70) \[[@B16-biomolecules-09-00008],[@B17-biomolecules-09-00008],[@B18-biomolecules-09-00008]\], a nuclear export protein \[[@B19-biomolecules-09-00008]\], the interferon regulatory factor 3 \[[@B20-biomolecules-09-00008],[@B21-biomolecules-09-00008]\], a cell receptor involved in MeV-induced immunosuppression \[[@B22-biomolecules-09-00008],[@B23-biomolecules-09-00008]\], peroxiredoxin 1 \[[@B24-biomolecules-09-00008]\], and proteins of the cell cytoskeleton \[[@B25-biomolecules-09-00008],[@B26-biomolecules-09-00008]\].

The N~TAIL~ and XD proteins interact with each other forming a 1:1 stoichiometric complex with an equilibrium dissociation constant (K~D~) in the μM range \[[@B27-biomolecules-09-00008],[@B28-biomolecules-09-00008]\]. The crystal structure of MeV XD has revealed that this domain consists of a bundle of three antiparallel α-helices \[[@B9-biomolecules-09-00008],[@B10-biomolecules-09-00008],[@B29-biomolecules-09-00008]\] ([Figure 1](#biomolecules-09-00008-f001){ref-type="fig"}B). In solution however, two distinct structural forms differing in their degree of compactness coexist \[[@B30-biomolecules-09-00008],[@B31-biomolecules-09-00008]\].

The structural arrangement of XD in a triple α-helical bundle, as well as the disordered nature of N~TAIL~ \[[@B32-biomolecules-09-00008]\], are also conserved in the related Nipah and Hendra viruses, whose N~TAIL~-XD complexes are similar to that of MeV \[[@B27-biomolecules-09-00008],[@B33-biomolecules-09-00008]\]. Binding to XD triggers α-helical folding of a short N~TAIL~ region (Box2, aa 486 to 504 of MeV N, and Box3, aa 473 to 493 of *Henipavirus* N), referred to as a Molecular Recognition Element or MoRE \[[@B7-biomolecules-09-00008],[@B9-biomolecules-09-00008],[@B10-biomolecules-09-00008],[@B27-biomolecules-09-00008]\] ([Figure 1](#biomolecules-09-00008-f001){ref-type="fig"}A). The MoREs are short, transiently populated secondary structures within IDRs that are often structurally biased towards their bound state \[[@B34-biomolecules-09-00008]\]. The crystal structure of a MeV chimeric construct in which XD is covalently attached to the MoRE of N~TAIL~ (aa 486 to 504) was solved at 1.8 Å \[[@B10-biomolecules-09-00008]\]. The structure consists of a pseudo-four helix complex in which the MoRE of N~TAIL~ adopts a parallel orientation with respect to XD and is embedded in a large hydrophobic cleft delimited by XD helices α2 and α3 \[[@B10-biomolecules-09-00008]\] ([Figure 1](#biomolecules-09-00008-f001){ref-type="fig"}C).

The MoRE is partly preconfigured as an α-helix in the absence of XD in both MeV and henipaviruses \[[@B5-biomolecules-09-00008],[@B29-biomolecules-09-00008],[@B33-biomolecules-09-00008],[@B35-biomolecules-09-00008],[@B36-biomolecules-09-00008],[@B37-biomolecules-09-00008],[@B38-biomolecules-09-00008]\]. This partial pre-configuration facilitates the folding-upon-binding process by rendering the structural transition to the (partially) folded conformation energetically less demanding \[[@B34-biomolecules-09-00008]\]. In spite of this pre-configuration, N~TAIL~ was shown to fold according to a folding-after-binding mechanism \[[@B28-biomolecules-09-00008],[@B33-biomolecules-09-00008],[@B39-biomolecules-09-00008],[@B40-biomolecules-09-00008]\].

Mutational studies coupled to Φ-value analysis led to a detailed structural description of the folding and binding events occurring in the recognition between MeV N~TAIL~ and XD \[[@B41-biomolecules-09-00008]\]. Analysis of the impact of single-amino acid substitutions in N~TAIL~ on the reaction mechanism allowed the identification of key residues involved in the initial recognition between N~TAIL~ and XD, and enabled unraveling of the general features of the folding pathway of N~TAIL~. In addition, analysis of the changes in stability of all the variants revealed that a few substitutions favor the folding step, which highlighted the inherent poor folding efficiency of N~TAIL~, a property that we proposed that could arise from the weakly funneled nature of the energy landscape of IDPs in their unbound state that might dictate a considerable structural heterogeneity (or structural frustration) of the bound state \[[@B41-biomolecules-09-00008]\].

In both MeV and henipaviruses, following binding to XD, most of N~TAIL~ remains disordered and does not establish stable contacts with XD \[[@B8-biomolecules-09-00008],[@B27-biomolecules-09-00008],[@B29-biomolecules-09-00008],[@B33-biomolecules-09-00008],[@B35-biomolecules-09-00008],[@B36-biomolecules-09-00008],[@B37-biomolecules-09-00008],[@B38-biomolecules-09-00008],[@B42-biomolecules-09-00008],[@B43-biomolecules-09-00008],[@B44-biomolecules-09-00008]\]. These N~TAIL~-XD complexes are therefore illustrative examples of fuzziness \[[@B45-biomolecules-09-00008]\]. Fuzziness may confer various functional advantages, such as the ability to interact with alternative partners and/or to establish simultaneous interactions with different partners. Fuzziness also provides a way to reduce the entropic penalty that accompanies the disorder-to-order transition, thereby leading to enhanced affinity. Tuning fuzziness therefore constitutes an additional manner by which IDPs can modulate the interaction strength with their partners. Furthermore, disordered appendages can harbor regulatory post-translational modification sites, can serve for partner fishing via non-specific, transient contacts, and can accommodate binding sites for additional partners \[[@B46-biomolecules-09-00008],[@B47-biomolecules-09-00008],[@B48-biomolecules-09-00008]\].

In line with these abilities, the C-terminal fuzzy region of MeV N~TAIL~ encompassing residues 517 to 525 was shown to serve as a low-affinity binding site for hsp70 \[[@B17-biomolecules-09-00008],[@B18-biomolecules-09-00008]\], a large cellular protein with a markedly different structural organization ([Figure 1](#biomolecules-09-00008-f001){ref-type="fig"}D) with respect to XD. The heat shock protein 70 (hsp 70) was shown to stimulate both viral transcription and replication, with this ability relying on interaction with N~TAIL~ \[[@B16-biomolecules-09-00008],[@B17-biomolecules-09-00008],[@B50-biomolecules-09-00008],[@B51-biomolecules-09-00008],[@B52-biomolecules-09-00008],[@B53-biomolecules-09-00008],[@B54-biomolecules-09-00008],[@B55-biomolecules-09-00008]\]. Binding experiments showed that the major hsp70-binding site is however located within Box2 \[[@B56-biomolecules-09-00008]\]. Since hsp70 was found to competitively inhibit the binding of XD to N~TAIL~ \[[@B17-biomolecules-09-00008]\], it has been proposed that hsp70 could enhance viral transcription and replication by destabilizing the P--N~TAIL~ interaction, thereby promoting successive cycles of binding and release that are essential for the polymerase to progress along the nucleocapsid template \[[@B8-biomolecules-09-00008],[@B17-biomolecules-09-00008]\]. The hsp70-dependent reduction of the stability of P--N~TAIL~ complexes would thus rely on competition between hsp70 and XD for binding to the α-MoRE of N~TAIL~, with recruitment of hsp70 being ensured by both Box2 and Box3 \[[@B17-biomolecules-09-00008]\]. Although the hsp70-binding site(s) within N~TAIL~ have been mapped, no structural information on the complex is available.

In the following sections we summarize available data pertaining to the impact of the long, N-terminal fuzzy appendage of N~TAIL~ on binding to both XD and hsp70. We also summarize the available molecular information on the sequence and secondary structure requirements for N~TAIL~-XD and N~TAIL~-hsp70 binding. Altogether, these studies contribute to enlarge our knowledge of the molecular determinants underlying the ability of hsp70 to interact with N~TAIL~ and, more generally, add "another brick to the wall" towards the ambitious goal of building up a comprehensive understanding of the mechanisms by which IDPs recognize their partners.

2. The N-Terminal Fuzzy Region of N~TAIL~ down Regulates the Binding of the MoRE to Both XD and Hsp70 {#sec2-biomolecules-09-00008}
=====================================================================================================

As recalled in the introduction, the MoRE of N~TAIL~ (aa 486 to 504) is responsible for XD binding and is preceded by a long, N-terminal fuzzy region (aa 401 to 488). We have investigated the role of this region by shortening it by ten residue intervals from aa 401 to aa 481 ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}A), and then assessing the binding ability of each truncation variant using a split-green fluorescent protein (GFP) complementation assay \[[@B57-biomolecules-09-00008],[@B58-biomolecules-09-00008]\]. In this assay, two proteins (X and Y) known to interact with each other are respectively fused to the C-terminal end of the first seven N-terminal moiety of GFP (NGFP) and the N-terminal end of the last four β-strands C-terminal moiety of GFP (CGFP) of GFP. Separately, NGFP-X and Y-CGFP are unable to fluoresce. However, when NGFP-X and Y-CGFP are co-expressed in *E. coli*, X and Y bind to each other within the cell, allowing NGFP and CGFP to reconstitute the full-length fluorescent GFP. Since the fluorescence is proportional to the affinity between X and Y \[[@B59-biomolecules-09-00008],[@B60-biomolecules-09-00008]\], the interaction between different combinations of NGFP-X and Y-CGFP can be compared by simply measuring the fluorescence of the bacteria co-expressing NGFP-X and Y-CGFP. In our case, X was N~TAIL~ or its truncation variants and Y was either XD or hsp70.

Results show a non-monotonic fluorescence increase with the truncation, with both XD ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}B) and hsp70 ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}C). In agreement with the known higher affinity of N~TAIL~ for XD (3 μM) \[[@B28-biomolecules-09-00008]\] compared to that for hsp70 (70 μM) \[[@B18-biomolecules-09-00008]\], the overall fluorescence was found to be higher for XD than for hsp70 (see the different Y-axis scales between [Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}B,C). Thus, the fuzzy N-terminal region of N~TAIL~ negatively regulates the binding of N~TAIL~ to two partners that differ in both size and affinity. We have obtained similar results when N~TAIL~ and XD from NiV and HeV were used \[[@B61-biomolecules-09-00008]\] or when another protein complementation assay based on split-luciferase \[[@B62-biomolecules-09-00008]\] was used. Thus, the negative effect of the fuzzy N-terminal region of N~TAIL~ on XD binding is shared by at least three paramyxoviruses and is maintained irrespective of whether the assay generates reversible (luciferase) or irreversible (GFP) complexes \[[@B61-biomolecules-09-00008]\].

We sought possible reasons for this negative effect. The importance of the primary structure of N~TAIL~ N-terminal region was first assessed. Since this region remains disordered after binding, a possible reason for its observed negative effect on binding could be its mere fuzziness. If this were the case, then swapping the wild-type sequence with another unrelated sequence would be expected to elicit similar effects provided that it is similarly disordered. To test this hypothesis, we replaced the wild-type N-terminal fuzzy region of N~TAIL~ (aa 401 to 480) with another non-natural sequence. Compared to its wild-type counterpart, this artificial sequence (i) has the same number of residues, (ii) is predicted to be slightly more disordered ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}D), (iii) shares only 6% identity. This artificial sequence was fused to the remaining part (aa 481 to 525) of wild-type N~TAIL~ to reconstitute an artificial full-length N~TAIL~ (aa 401 to 525) (artN~TAIL~). We then generated the same series of truncation variants as those previously generated from the wild-type sequence (wtN~TAIL~) ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}A) and compared their effect on the binding to XD. As shown in [Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}E, wtN~TAIL~ and artN~TAIL~ truncation variants yielded similar binding patterns, with the binding strength increasing non-monotonically with the truncation. However, results were not identical. Compared to wtN~TAIL~, the profile obtained with artN~TAIL~ was more linear, and each artN~TAIL~ variant displayed a slightly lower interaction strength towards XD than its wild-type counterpart, a property that could be related to the higher disorder probability of full-length artN~TAIL~ ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}D). Thus, the negative effect of N~TAIL~ N-terminal fuzzy region (aa 401 to 485) on XD binding was not due to its specific sequence but to a combination of length and fuzziness. The sequence-independent nature of the effect exerted by the disordered appendage is not unique to N~TAIL~, having also been observed in the case of human UDP-α-D-glucose-6-dehydrogenase. This enzyme possesses a C-terminal disordered region that entropically rectifies the dynamics and structure of the enzyme to favor binding of an allosteric inhibitor, with this effect being independent from both primary structure and chemical composition \[[@B63-biomolecules-09-00008]\].

We tried to perform the same experiments using hsp70, but got results suffering from low reproducibility for unknown reasons (not illustrated). We further investigated the molecular mechanisms by which the fuzzy appendage of MeV N~TAIL~ influences the interaction with XD by analyzing binding kinetics ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}F). In the case of full-length N~TAIL~ (aa 401--525), a hyperbolic dependence of *k~obs~* (the macroscopic observed rate constant) on ligand concentration was observed, which accounts for the folding of N~TAIL~ becoming rate-limiting at high reactant concentrations \[[@B28-biomolecules-09-00008]\]. Conversely, when a MoRE-mimicking peptide (aa 485 to 506) was used, linear kinetics was observed. Kinetic experiments could not be performed using hsp70 because of the low affinity of the interaction, and due to the presence of numerous tryptophan residues that could jeopardize the analysis. In conclusion, the N~TAIL~ N-terminal region could dampen the N~TAIL~/XD interaction, at least in part, by lowering the rate of folding of the MoRE, although the subtle mechanisms underlying this ability remain elusive and await future studies to be unraveled.

3. The Bindings of XD and Hsp70 to N~TAIL~ MoRE Rely on Different Primary and Secondary Structure Requirements {#sec3-biomolecules-09-00008}
==============================================================================================================

We have seen that MeV N~TAIL~ N-terminal region (401 to 485) has comparable negative effects on the binding of two different N~TAIL~ partners: XD, a small viral protein \[[@B9-biomolecules-09-00008]\] with a relatively high affinity (3 μM) \[[@B28-biomolecules-09-00008]\] and hsp70, a large cellular protein with a lower affinity (70 μM) for N~TAIL~ \[[@B18-biomolecules-09-00008]\]. Although the MoRE has been shown to be the major hsp70-binding site \[[@B17-biomolecules-09-00008],[@B18-biomolecules-09-00008]\], the structure of N~TAIL~-hsp70 complex has not been solved yet contrary to the N~TAIL~-XD complex \[[@B10-biomolecules-09-00008]\]. As a consequence, we do not know whether the MoRE folds into an α-helix upon binding to hsp70 as it does upon XD binding and whether the interaction relies on the same MoRE residues. The relevance of investigating the molecular mechanisms governing the N~TAIL~/hsp70 interaction lies in its well-documented impact on viral transcription and replication \[[@B16-biomolecules-09-00008],[@B17-biomolecules-09-00008]\] and on the innate immune response \[[@B65-biomolecules-09-00008]\].

3.1. Sequence Requirements of N~TAIL~ Molecular Recognition Element for XD and Hsp70 Binding {#sec3dot1-biomolecules-09-00008}
--------------------------------------------------------------------------------------------

To gain insights into this biologically relevant question, we first alanine scanned the MoRE, and assessed the effect of these substitutions by monitoring the binding of each individual variant to XD and hsp70 using the split-GFP complementation assay \[[@B64-biomolecules-09-00008]\]. We used N~TAIL~ truncation variant 471 (aa 471 to 525) as backbone to derive single-site variants because it binds XD better than full-length N~TAIL~ ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}B) \[[@B61-biomolecules-09-00008]\], and therefore provides higher fluorescence signals in split-GFP complementation assay that are more appropriate than weak signals to study subtle modulation effects. In the case of XD binding ([Figure 3](#biomolecules-09-00008-f003){ref-type="fig"}A), most alanine variants exhibited a decreased binding compared to that of the wild-type sequence and, in a few cases (residues Ser491, Ala494, Leu495, Met501), the single alanine (or glycine) substitution essentially abrogates binding \[[@B66-biomolecules-09-00008]\]. These latter residues can therefore be defined as critical for XD binding, a conclusion in agreement with the 3D structure of the MeV MoRE-XD complex in which all these residues point toward XD and not to the solvent \[[@B10-biomolecules-09-00008]\]. Very different results were obtained with hsp70 ([Figure 3](#biomolecules-09-00008-f003){ref-type="fig"}B) \[[@B64-biomolecules-09-00008]\]. First, several variants exhibited an increased binding compared to the wild-type sequence. Secondly, no single residue proved to be mandatory for binding to hsp70. Thus, although N~TAIL~ binding to both XD and hsp70 was down-regulated by the N~TAIL~ N-terminal fuzzy region ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}), these two proteins bind the MoRE using different residues thereof, and hence through different mechanisms.

Based on the results provided by the alanine-scanning mutagenesis, we conceived an hsp70 "super binder" (hsb) that was obtained by collectively introducing all the substitutions that individually increased the binding to hsp70 (see [Figure 4](#biomolecules-09-00008-f004){ref-type="fig"}A) in the context of truncated variant 471 (hsb471). This rationally designed variant displayed a much higher binding strength (2.35 times) towards full-length hsp70 than wt471 in a split-GFP complementation assay (compare wt471 to hsb471 and wtMoRE to hsbMoRE in [Figure 4](#biomolecules-09-00008-f004){ref-type="fig"}B). Because of the dampening effect of the N-terminal fuzzy appendage ([Figure 2](#biomolecules-09-00008-f002){ref-type="fig"}C), this enhancement in affinity was even more pronounced when hsbMoRE was used alone rather than in the context of truncated variant 471 (compare hsb471 and hsbMoRE bindings in [Figure 4](#biomolecules-09-00008-f004){ref-type="fig"}B).

The three-fold increase in binding strength towards hsp70 upon replacement of as many as 13 residues out of 19 (i.e., almost 70%) of the sequence of the wtMoRE with alanine or glycine ([Figure 4](#biomolecules-09-00008-f004){ref-type="fig"}A) is puzzling. How can N~TAIL~ binding to hsp70 be specific of the MoRE while being relatively independent of the sequence of the latter? Conceivably, hsp70 may recognize not a precise amino acid sequence or motif, but rather a set of few residues with specific chemical features and no strict positional conservation. While hydrophobicity on its own cannot explain the increased binding strength of hsbMoRE \[[@B64-biomolecules-09-00008]\], the enrichment in Ala, Gly, and Leu residues (in this order) and the depletion in Asp residues of hsbMoRE ([Figure 4](#biomolecules-09-00008-f004){ref-type="fig"}A) might provide a rational explanation: indeed, previous studies identified these features as favoring binding of peptides to hsp33, a redox-regulated chaperone \[[@B67-biomolecules-09-00008]\].

3.2. Secondary Structure Requirements of N~TAIL~ Molecular Recognition Element for XD and Hsp70 Binding {#sec3dot2-biomolecules-09-00008}
-------------------------------------------------------------------------------------------------------

Single residue substitutions of the alanine scanning aimed at providing information on the sequence requirement of XD and hsp70 binding but not at changing the secondary structure of the MoRE. The latter is known to fold into an α-helix upon XD binding. However, nothing is known about the conformation it takes upon binding to hsp70. To address this question, we constructed two MoRE variants with opposite folding properties \[[@B66-biomolecules-09-00008]\]. Both MoRE variants were generated using truncation variant 471 as backbone for the reason given above. In the first one (Ala471), all residues the alanine scanning identified as non-critical for XD binding were replaced with alanine. In the second one (Gly471), those residues were replaced with glycine. Since alanine promotes α-helix formation whereas glycine has the opposite effect \[[@B68-biomolecules-09-00008]\], Ala471 and Gly471 were expected to be more and less α-helical than wtMoRE, respectively. This assumption, strengthened by disorder prediction and modeling \[[@B66-biomolecules-09-00008]\], was experimentally confirmed by circular dichroism (CD) analysis of MoRE peptides ([Figure 3](#biomolecules-09-00008-f003){ref-type="fig"}C).

The wt471, Ala471, and Gly471 variants were then tested for their ability to bind XD or hsp70 by split-GFP complementation assay. Results ([Figure 3](#biomolecules-09-00008-f003){ref-type="fig"}D, left panel), indicated that increasing the α-helicity (Ala471) slightly increased binding to XD compared to wt471, whereas the lack of α-helicity (Gly471) resulted in a complete loss of binding in spite of the presence of the residues revealed to be critical for XD binding by alanine scanning \[[@B64-biomolecules-09-00008]\]. Conversely, Ala471 and Gly471 behaved similarly when assessed for their binding to hsp70: they both exhibited a moderately decreased binding compared to wt471 ([Figure 3](#biomolecules-09-00008-f003){ref-type="fig"}D, right panel) \[[@B66-biomolecules-09-00008]\]. The lower XD binding ability of Gly471 compared to that of wt471 and Ala471 was also confirmed by kinetics experiments ([Figure 3](#biomolecules-09-00008-f003){ref-type="fig"}E). While AlaMoRE and wtMoRE behaved similarly, there was a detectable destabilization of the complex in the case of GlyMoRE as judged from the lower slope of its binding kinetics \[[@B64-biomolecules-09-00008]\]. These results definitely indicate that XD and hsp70 did not rely on the same structural requirements to bind to the MoRE of N~TAIL~. More specifically, increasing the α-helicity of the MoRE increased XD binding but decreased hsp70 binding suggesting that the latter did not trigger α-helical folding of the MoRE, a conclusion strengthened by the ability of hsp70 to bind a MoRE that is unable to fold into an α-helix.

In conclusion, in addition to using a different set of N~TAIL~ residues, XD and hsp70 did not induce the same folding within the MoRE, therefore indicating that they likely interacted with N~TAIL~ through completely different mechanisms.

4. Conclusions {#sec4-biomolecules-09-00008}
==============

Deletion studies have shown that the long, N-terminal fuzzy region of N~TAIL~ inhibits the interaction with XD and hsp70. This raises the question of what could be the possible functional role of this auto-inhibition. According to the so-called cartwheeling mechanism, the N~TAIL~-XD interaction needs to be dynamically made and broken to ensure progression of the polymerase complex onto the nucleocapsid to allow transcription and replication \[[@B69-biomolecules-09-00008]\]. A too strong interaction between N~TAIL~ and XD is therefore predicted to hinder the polymerase processivity. The discovery that the fuzzy appendage acts as a natural dampener of the interaction provides a conceptual framework to understand why the MoRE is preceded by such a long arm. It is tempting to speculate that in the course of evolution, the length of this region has been under selective pressure so as to ensure an optimal affinity towards XD. This speculation is in agreement with recent studies by the group of Plemper that showed that a mutated measles virus in which the region preceding the MoRE has been shortened suffers from an imbalance between transcription and replication \[[@B70-biomolecules-09-00008]\].

Alanine-scanning mutagenesis of the MoRE unveiled that XD is very sensitive to substitutions, in line with experimental evidence showing that the MoRE of N~TAIL~ is poorly evolvable in terms of XD binding \[[@B58-biomolecules-09-00008]\]. This implies that the sequence of the MoRE has been shaped during evolution to achieve maximal binding to XD, a finding in striking contrast with the postulated positive selection of a long fuzzy appendage dampening the interaction. Although apparently contradictory, these effects of natural selection have in fact resulted in a finely tuned system in which the strongest possible MoRE-XD interaction is "entropically rectified" \[[@B63-biomolecules-09-00008]\] by the N-terminal fuzzy region of N~TAIL~ to achieve a precise N~TAIL~-XD interaction strength. The latter is in fact required to ensure dynamic anchoring of the L--P polymerase complex \[[@B71-biomolecules-09-00008]\] and efficient transcription re-initiation at each intergenic junction of the MeV genome \[[@B72-biomolecules-09-00008]\].

By contrast, hsp70 is much more tolerant to substitutions within the MoRE, and the MoRE-hsp70 interaction appears to be highly evolvable. The high evolvability of the N~TAIL~-hsp70 interaction might arise from the fact that the two binding partners have not been subjected to an as tight co-evolution as that of the N~TAIL~-XD pair due to the multiple functional roles that hsp70 plays in the cell and that are not exclusively related to MeV infection. In addition, a high affinity between N~TAIL~ and hsp70 might not be required for the interaction to take place and elicit the known effects on viral transcription and replication \[[@B17-biomolecules-09-00008],[@B73-biomolecules-09-00008]\] and on the innate immune response \[[@B65-biomolecules-09-00008]\] given the very high intracellular concentrations of both hsp70 and N in MeV infected cells \[[@B53-biomolecules-09-00008]\]. A high affinity could even be deleterious for the viral replication since hsp70 could then fully out compete XD for N~TAIL~ binding \[[@B17-biomolecules-09-00008]\].

The discovery that the N~TAIL~-hsp70 interaction does not rely on the same residues mediating the N~TAIL~-XD interaction, and does not imply α-helical folding emphasizes the plasticity and polymorphism of this IDP. The structure adopted in the bound form seems therefore to be "sculpted" by the partner, thereby providing an additional example of "templated folding" \[[@B41-biomolecules-09-00008]\]. This high extent of malleability with respect to the partner challenges the role of preconfiguration of MoREs in the recognition process. N~TAIL~ seems indeed to be relatively insensitive to the structure of its pre-recognition motif, being able to adopt a non α-helical conformation upon binding to hsp70 in spite of the partial α-helical preconfiguration of its MoRE.

Finally, and from a more applied perspective, the much higher affinity of hsb compared to wt MoRE towards hsp70 holds promise for future potential therapeutic applications. Since the N~TAIL~-hsp70 interaction stimulates viral transcription and replication \[[@B16-biomolecules-09-00008],[@B17-biomolecules-09-00008]\], and since hsbMoRE binds hsp70 three times better than wtMoRE, over-expressing hsbMoRE in MeV-infected cells might expectedly inhibit MeV replication (provided that hsbMoRE is non-toxic for eukaryotic cells). Incidentally, hsbMoRE could also be used as an anti-cancer drug, based on previous studies that have described the anti-viral \[[@B74-biomolecules-09-00008]\] and anti-cancer \[[@B75-biomolecules-09-00008],[@B76-biomolecules-09-00008]\] effect of 2-phenylethynesulfonamide, a specific hsp70 inhibitor. Experiments are ongoing in our lab to assess the therapeutic potential of hsbMoRE.
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![(**A**) Schematic representation of the C-terminal domain of the nucleoprotein (N) of measles virus (MeV) N~TAIL~ (upper panel) and cartoon representation of an N~TAIL~ conformer generated using Flexible-Mecano \[[@B49-biomolecules-09-00008]\]. (**B**) Ribbon representation of the crystal structure of the C-terminal X domain of the phosphoprotein of MeV XD (PDB code 1OKS). (**C**) The structure of the chimeric construct made of MeV XD (blue) and of the molecular recognition element MoRE of N~TAIL~ (red) (PDB code 1T6O). (**D**) Cartoon representation of the crystal structure of hsp70 based on PDB codes 1HJO and 4JNF. The relative orientation of the two hsp70 domains (i.e., amino acids 3 to 382 and amino acids 389 to 610) is based on the structure of a form encompassing residues 1 to 554 (PDB code 1YUW). The three constituent domains of hsp70, i.e., nucleotide binding domain (NBD, aa 1 to 384), peptide binding domain (PBD, aa 384 to 543) and "lid" (aa 543 to 641) (see \[[@B18-biomolecules-09-00008]\] and references therein cited) are highlighted.](biomolecules-09-00008-g001){#biomolecules-09-00008-f001}

![Effect of the N-terminal fuzzy region of N~TAIL~ on XD and hsp70 binding. (**A**) N~TAIL~ deletion variants were generated as described \[[@B60-biomolecules-09-00008]\]. The N-terminal residue is indicated. The N-terminal fuzzy region subjected to truncation is shown in grey and the MoRE is shown in green. (**B**,**C**) Split- green fluorescent protein (GFP) complementation assay using XD (**B**) and hsp70 (**C**). Shown are the mean values and standard deviation (SD) of an experiment performed in triplicate. Results are expressed as percentage with 100% being the fluorescence value provided by full-length N~TAIL~ (401). For a detailed description of the procedure see [Supplementary Information](#app1-biomolecules-09-00008){ref-type="app"}. (**D**) IUPred \[[@B64-biomolecules-09-00008]\] disorder prediction of wtN~TAIL~ (blue) and artN~TAIL~ (red) from residue 401 to residue 480. (**E**) Fluorescence values obtained by split-GFP complementation assays using wild type (wt) (blue line) and art (red line) N~TAIL~ truncation variants and XD. Shown are the mean values and SD of an experiment performed in triplicate. Results are expressed as percentage with 100% being the fluorescence value provided by full-length wtN~TAIL~ (401). (**F**) Binding kinetics of XD (at a constant concentration of 2 μM) with excess concentrations of either wtNTAIL (black circles) or a peptide mimicking the MoRE (green circles) in 10 mM sodium phosphate buffer and 150 mM NaCl at pH 7.0. Under all conditions, there was an at least fivefold difference in concentration between the two proteins to ensure pseudo-first order conditions. Experiments were carried out using a PTJ-64 capacitor-discharge T-jump apparatus (Hi-Tech, Salisbury, UK). The temperature was rapidly changed with a jump size of 9 °C, from 11 °C to 20 °C. Data were taken from \[[@B60-biomolecules-09-00008]\].](biomolecules-09-00008-g002){#biomolecules-09-00008-f002}

![Effect of primary and secondary structures of the MoRE on XD and hsp70 binding. (**A**,**B**) Alanine scanning mutagenesis of N~TAIL~ MoRE. MoRE residues (aa 486 to 504) of MeV N~TAIL~ truncation variant 471 were individually mutated into an alanine (or a glycine when the wild-type residue was an alanine). The binding ability of each single N~TAIL~ variant was then compared to that of wild-type N~TAIL~ by split-GFP complementation assay using either XD (**A**) or hsp70 (**B**). Ø, negative control (fluorescence background obtained using an empty vector encoding NGFP alone); wt, positive control (i.e., wild-type truncation variant 471). Results are expressed as percentage with 100% being the fluorescence value provided by wt truncation variant 471. The horizontal dotted line indicates the binding of the positive control. (**C**) Far-UV circular dichroism spectra of wtMoRE, AlaMoRE, and GlyMoRE peptides. (**D**) Fluorescence values obtained by split-GFP complementation assays using N~TAIL~ MoRE variants with different α-helicities. See A for details; 401, full-length wtN~TAIL~; wt471, 471 truncated variant with a wtMoRE; Ala471, 471 truncated variant with AlaMoRE; Gly471, 471 truncated variant with GlyMoRE. (**E**) Binding kinetics of MoRE peptides to XD. Data shown in panels A, B, and D are the mean values and SD of an experiment performed in triplicate. Data were taken from \[[@B66-biomolecules-09-00008]\].](biomolecules-09-00008-g003){#biomolecules-09-00008-f003}

![Binding abilities of hsb towards hsp70. (**A**) Amino acid sequence of wt and hsbMore. In the latter, all the residues individually shown to lead to increased N~TAIL~-hsp70 binding strength by the alanine scanning mutagenesis were collectively replaced with alanine, or with glycine when the wild-type residue was alanine. (**B**) Binding abilities of N~TAIL~ variants as obtained by split-GFP complementation assays. *Y*-axis: fluorescence values of each culture divided by the optical density at 600 nm. *X*-axis: N~TAIL~ variants-hsp70 pairs. Shown are the mean values and SD of an experiment performed in triplicate. The scheme of the N~TAIL~ constructs is shown above the graph, with wt and hsb MoREs being represented in grey and black, respectively, and fuzzy regions in white. Orientation is from left (N-terminal end) to right (C-terminal end). Data were taken from \[[@B66-biomolecules-09-00008]\].](biomolecules-09-00008-g004){#biomolecules-09-00008-f004}
